Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec.

Gilca R, De Wals P, Nolan SM, Kitchin N, Eiden JJ, Jiang Q, Jones CH, Jansen KU, Anderson AS, Pedneault L.

mSphere. 2018 Dec 5;3(6). pii: e00427-18. doi: 10.1128/mSphere.00427-18.

2.

Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study.

van Ravenhorst MB, Bijlsma MW, van Houten MA, Struben VMD, Anderson AS, Eiden J, Hao L, Jansen KU, Jones H, Kitchin N, Pedneault L, Sanders EAM, van der Ende A.

Clin Microbiol Infect. 2017 Aug;23(8):573.e1-573.e7. doi: 10.1016/j.cmi.2017.02.008. Epub 2017 Feb 10.

3.

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.

Sheldon E, Kitchin N, Peng Y, Eiden J, Gruber W, Johnson E, Jansen KU, Pride MW, Pedneault L.

Vaccine. 2016 Apr 19;34(18):2082-91. doi: 10.1016/j.vaccine.2016.03.010. Epub 2016 Mar 15.

PMID:
26993331
4.

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Jones CH, Mohamed N, Rojas E, Andrew L, Hoyos J, Hawkins JC, McNeil LK, Jiang Q, Mayer LW, Wang X, Gilca R, De Wals P, Pedneault L, Eiden J, Jansen KU, Anderson AS.

J Clin Microbiol. 2016 Jan;54(1):25-34. doi: 10.1128/JCM.01447-15. Epub 2015 Aug 26.

5.

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.

Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, Ladhani S, Okike IO, Oeser C, Kent A, Oliver J, Taylor P, Morales-Aza B, Clarke SC, Casey M, Martins F, Kitchin NR, Anderson AS, Jones H, Jansen KU, Eiden J, Pedneault L, Heath PT, Finn A, Faust SN, Pollard AJ.

J Infect. 2015 Jul;71(1):43-52. doi: 10.1016/j.jinf.2015.02.006. Epub 2015 Feb 21.

6.

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

Lichterfeld M, Gandhi RT, Simmons RP, Flynn T, Sbrolla A, Yu XG, Basgoz N, Mui S, Williams K, Streeck H, Burgett-Yandow N, Roy G, Janssens M, Pedneault L, Vandepapelière P, Koutsoukos M, Demoitié MA, Bourguignon P, McNally L, Voss G, Altfeld M.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):1-9. doi: 10.1097/QAI.0b013e3182373b77.

7.

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

Leroux-Roels I, Koutsoukos M, Clement F, Steyaert S, Janssens M, Bourguignon P, Cohen K, Altfeld M, Vandepapelière P, Pedneault L, McNally L, Leroux-Roels G, Voss G.

Vaccine. 2010 Oct 8;28(43):7016-24. doi: 10.1016/j.vaccine.2010.08.035. Epub 2010 Aug 20.

PMID:
20728522
8.

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.

Goepfert PA, Tomaras GD, Horton H, Montefiori D, Ferrari G, Deers M, Voss G, Koutsoukos M, Pedneault L, Vandepapeliere P, McElrath MJ, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Baden LR, Harro C, Evans T; NIAID HIV Vaccine Trials Network.

Vaccine. 2007 Jan 5;25(3):510-8. Epub 2006 Aug 10.

PMID:
17049679
9.

European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.

Lehner T, Hoelscher M, Clerici M, Gotch F, Pedneault L, Tartaglia J, Gray C, Mestecky J, Sattentau Q, van de Wijgert J, Toure C, Osmanov S, Schmidt RE, Debre P, Romaris M, Hoeveler A, Di Fabio S.

Vaccine. 2005 Dec 1;23(48-49):5551-6. Epub 2005 Jul 20.

PMID:
16153752
10.

Do we use too much antenatal betamethasone?

Skoll A, Ferreira E, Pedneault L, Duchesne M, Létourneau G.

J Obstet Gynaecol Can. 2002 Apr;24(4):330-4.

PMID:
12196869
11.

Metabolic complications associated with antiretroviral therapy.

Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM.

Antiviral Res. 2001 Sep;51(3):151-77. Review.

PMID:
11448728
12.

A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir.

Eron JJ, Haubrich R, Lang W, Pagano G, Millard J, Wolfram J, Snowden W, Pedneault L, Tisdale M.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):458-61.

PMID:
11391165
13.

Safety profile and tolerability of amprenavir in patients enrolled in an early access program.

Scott T, Garris C, Rogers M, Graham N, Garrett L, Pedneault L.

Clin Ther. 2001 Feb;23(2):252-9.

PMID:
11293558
14.

Recurrent cleft lip and palate in siblings of a patient with malabsorption syndrome, probably caused by hypovitaminosis a associated with folic acid and vitamin B(2) deficiencies.

Faron G, Drouin R, Pedneault L, Poulin LD, Laframboise R, Garrido-Russo M, Fraser WD.

Teratology. 2001 Mar;63(3):161-3.

PMID:
11283973
15.

Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection.

Pedneault L, Brothers C, Pagano G, Tymkewycz P, Yeo J, Millard J, Fetter A.

Clin Ther. 2000 Dec;22(12):1378-94; discussion 1377.

PMID:
11192131
16.

Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.

Goodgame JC, Pottage JC Jr, Jablonowski H, Hardy WD, Stein A, Fischl M, Morrow P, Feinberg J, Brothers CH, Vafidis I, Nacci P, Yeo J, Pedneault L.

Antivir Ther. 2000 Sep;5(3):215-25.

PMID:
11075942
17.

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

DeGruttola V, Dix L, D'Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray J, Patick A, Miller V, Castillo S, Pedneault L, Mellors J.

Antivir Ther. 2000 Mar;5(1):41-8.

PMID:
10846592
18.

Antiretroviral resistance testing comes of age.

Hammer SM, Pedneault L.

Antivir Ther. 2000 Mar;5(1):23-6. No abstract available.

PMID:
10846589
19.

Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers.

Pedneault L, Lapointe N, Alfieri C, Ghadirian P, Carpentier L, Samson J, Joncas J.

J Infect Dis. 1998 Apr;177(4):1087-90.

PMID:
9534989
20.
21.

Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis.

Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L, Spier S.

J Pediatr. 1997 Apr;130(4):584-93.

PMID:
9108857
22.
24.

Unilateral laterothoracic exanthem. A clinicopathologic study of forty-eight patients.

McCuaig CC, Russo P, Powell J, Pedneault L, Lebel P, Marcoux D.

J Am Acad Dermatol. 1996 Jun;34(6):979-84.

PMID:
8647991
25.

[Rubella: epidemiology, diagnosis and prevention].

Rouleau D, Pedneault L.

Union Med Can. 1995 Nov;124(3):2-7. French. No abstract available.

PMID:
8560633
26.

Validation of respiratory syncytial virus enzyme immunoassay and shell vial assay results.

Pedneault L, Robillard L, Turgeon JP.

J Clin Microbiol. 1994 Nov;32(11):2861-4.

27.

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

Boivin G, Edelman CK, Pedneault L, Talarico CL, Biron KK, Balfour HH Jr.

J Infect Dis. 1994 Jul;170(1):68-75.

PMID:
8014522
28.
29.

Acute aqueductal stenosis in a patient with Epstein-Barr virus infectious mononucleosis.

Cotton MF, Reiley T, Robinson CC, Pedneault L, Alfieri C, Simoes EA.

Pediatr Infect Dis J. 1994 Mar;13(3):224-7. No abstract available.

PMID:
8177631
30.

Comparison of four enzyme immunoassays for the detection of cytomegalovirus IgG antibodies.

Pedneault L, Robillard L, Harvey P, Joncas J.

Clin Diagn Virol. 1993 Oct;1(4):215-23.

PMID:
15566735
31.
33.

Detection of Epstein-Barr virus in the brain by the polymerase chain reaction.

Pedneault L, Katz BZ, Miller G.

Ann Neurol. 1992 Aug;32(2):184-92.

PMID:
1324632
34.

Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis.

de Repentigny L, Kilanowski E, Pedneault L, Boushira M.

J Infect Dis. 1991 Jun;163(6):1305-11.

PMID:
2037796
35.

Long term treatment with CV 205-502 in patients with prolactin-secreting pituitary macroadenomas.

Serri O, Beauregard H, Lesage J, Pedneault L, Comtois R, Jilwan N, Somma M, Vachon L, Brownell J.

J Clin Endocrinol Metab. 1990 Sep;71(3):682-7.

PMID:
2394774
36.

Production and characterization of monoclonal antibodies to cell wall antigens of Aspergillus fumigatus.

Ste-Marie L, Sénéchal S, Boushira M, Garzon S, Strykowski H, Pedneault L, de Repentigny L.

Infect Immun. 1990 Jul;58(7):2105-14.

37.

[Colitis caused by amoxicillin].

Pedneault L, Letendre JF, Côté S, Séguin R.

Union Med Can. 1986 Mar;115(3):151-4. French. No abstract available.

PMID:
3705263
38.

Effect of aminoglycosides on the disposition of thyroid hormones and thyroglobulin.

du Souich P, Pison C, Pedneault L, Larochelle P, Morisset R, Vega C, Phaneuf D, Poisson M.

Clin Pharmacol Ther. 1985 Dec;38(6):686-91.

PMID:
4064470

Supplemental Content

Loading ...
Support Center